In looking at Mr. Garneau's amendment and then at the existing Patent Act, what this appears to be doing is simply reinstating the wording from the existing Patent Act. It talks about reinserting the words “patented product listed in Schedule 1...if applicable, the dosage form, the strength and the route of administration specified in that Schedule in relation to the product”.
But for some reason—and I guess this is what we're trying to figure out, Mr. Garneau--you're reinstating the old definition for pharmaceutical product, except for one little exception. You're adding the words “on the recommendation of the Minister and the Minister of Health”. Those words are found in the existing Patent Act in paragraph 21.03(1)(a).
I'm just wondering why you've mixed two clauses that have both been removed under Bill C-393 and have reinserted them under the definition of pharmaceutical product. I'm wanting an idea of what the rationale is there.